Cerebral Palsy
Gene: SOX2
Additional report of a 12 year old girl with a spastic and dystonic movement disorder diagnosed as CP and found to have a de novo loss of function variant in SOX2 (same child reported in both PMID: 39736497; https://doi.org/10.1186/s43042-025-00665-z). Notably, she did not have ocular symptoms.Created: 24 Oct 2025, 10:22 a.m. | Last Modified: 24 Oct 2025, 10:22 a.m.
Panel Version: 1.397
Single individual with de novo frameshift deletion described in WGS study of clinically confirmed CP (PMID: 38553553). SOX2 disorders are associated with a spectrum of phenotypes which frequently include psychomotor delay, hypotonia, dystonia (including status dystonicus), spastic diplegia/quadriplegia.
Sources: LiteratureCreated: 27 Jun 2024, 2:45 p.m.
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes
Microphthalmia, syndromic 3; Optic nerve hypoplasia and abnormalities of the central nervous system, MIM#206900
Publications
Publications for gene: SOX2 were set to 38553553; 39736497
Publications for gene: SOX2 were set to PMID: 38553553
Gene: sox2 has been classified as Amber List (Moderate Evidence).
Gene: sox2 has been classified as Red List (Low Evidence).
Gene: sox2 has been classified as Red List (Low Evidence).
gene: SOX2 was added gene: SOX2 was added to Cerebral Palsy. Sources: Literature Mode of inheritance for gene: SOX2 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Publications for gene: SOX2 were set to PMID: 38553553 Phenotypes for gene: SOX2 were set to Microphthalmia, syndromic 3; Optic nerve hypoplasia and abnormalities of the central nervous system, MIM#206900 Review for gene: SOX2 was set to RED